Intelligent Bio Solutions (NASDAQ:INBS) Shares Down 2.1% – Here’s Why

Intelligent Bio Solutions Inc. (NASDAQ:INBS) dropped 2.1% on Tuesday . The company traded as low as $1.39 and last traded at $1.43. Approximately 74,089 shares traded hands during trading, a decline of 15% from the average daily volume of 87,097 shares. The stock had previously closed at $1.46.

Intelligent Bio Solutions Trading Down 1.4 %

The firm has a fifty day simple moving average of $1.51 and a 200-day simple moving average of $1.55.

Intelligent Bio Solutions (NASDAQ:INBS) last released its quarterly earnings results on Thursday, November 7th. The company reported ($0.70) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.53) by ($0.17). The company had revenue of $872.29 million for the quarter. Intelligent Bio Solutions had a negative return on equity of 147.50% and a negative net margin of 288.35%. As a group, equities analysts anticipate that Intelligent Bio Solutions Inc. will post -1.25 earnings per share for the current fiscal year.

Intelligent Bio Solutions Company Profile

Intelligent Bio Solutions Inc, a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities.